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1.1. Molecular mechanisms of point mutations
Point mutations refer to mutational events that involve one
single base of the gene irrespective of the size of the gene.
Lethal genetic diseases can be caused by single point muta-
tions, even in very large genes. A well known example is Duch-
enne myopathy due to single point mutations of the dystrophin
gene which is the largest human gene composed of 2.4 million
bases. Sickle cell anemia is another example of a drastic genetic
disease resulting from a single point mutation of the beta glo-
bin gene. Point mutations account for nearly 70% of currently
deﬁned human single gene disorders [1].
Molecular mechanisms of point mutation comprise a wide
spectrum of alterations at the molecular level of the genetic
material (Fig. 1). These mechanisms include replacement of
one base (nucleotide) of the gene by another base, deletion,
or loss, of one base of the gene, addition of one base to the
gene or change in the structure of one base of the gene, e.g.
by methylation, acetylation etc. Replacement of one base by
another base may not affect the function of the gene or, on
the other hand, can have drastic effects on gene function
according to the type and consequences of the change. If one
base of a functional codon is replaced by another base chang-
ing the codon to another codon specifying the same amino
acid, due to degeneracy of the genetic code, then no change* Tel.: +20 01225874345/33354379.
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no pathological alterations happen. This type of point muta-
tion is called same-sense mutation since no change in protein
structure happens. If the resulting new codon speciﬁes a differ-
ent amino acid a missense mutation results, the effects of which
depend on the role played by the new amino acid in protein
functioning. If the new amino acid has an important role with-
in a critical functional domain of the protein, then pathophys-
iological alteration(s) of the function(s) of the protein is
expected and defective function leading to pathogenesis of a
genetic defect might ensue. If base replacement results in the
formation of a new stop or termination codon, a status termed
non-sense mutation, the resulting alterations depend on many
factors. If the mutation happens at the beginning of the coding
part of the gene, most of the protein coded by the gene will not
be translated from this point on. A short, or truncated, mostly
non-functional protein will be synthesized and marked deteri-
oration of gene function might result. If the mutation happens
at or near the end of the coding part of the gene, most of the
protein coded by the gene will be translated and less, or no
change, of gene function might result. In both situations, the
resulting pathogenetic alterations depend on the physiological
role(s) played by the missing domain(s) of the protein. If these
roles are important in mediating functions of vital metabolic
networks in the cell, then genetic defects will happen and path-
ogenesis of a genetic disorder might ensue.
Deletion or addition of one base within the gene will result in
shifting of the reading frame of the newly formed codons. This
type of point mutation is called frame-shift mutation. The
resulting effects may lead to the formation of new same-sense,
missense or stop termination codons with ultimate conse-
quences similar to the results of the similar aforementioned
mechanisms. These same rules apply for mutational events
involving the addition or deletion of two bases. If three bases
are added or deleted, a whole new codon will be added orier B.V. All rights reserved.
Figure 1 Molecular mechanisms of point mutation.
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don to a functional exon of the gene might result in a wide spec-
trum of alterations as previously explained, whole codon
addition or deletion within non-coding parts of the gene, in-
trons, has no effect on translated protein or on gene function [2].
Change in the structure of one base of the gene, e.g. meth-
ylation of cytosine, can affect gene transcription through sev-
eral different mechanisms. Each cell has a speciﬁc
methylation pattern necessary for normal cell differentiation
during development. Changes in this pattern by mutations of
regulatory genes controlling its timing and its magnitude can
have marked deteriorating effects on the cell during differenti-
ation. This type of mutation must not be confused with epige-
netic mutations that involve structural changes in the
chromatin or the DNA-associated proteins rather than the
DNA itself [3].
1.2. Molecular mechanisms of small mutations
Small mutations are arbitrarily classiﬁed so as to comprise
structural changes involving more than one base, part of a
gene, a whole gene or few genes. They span a wide spectrum
of structural genetic changes involving addition or removal
of two bases leading to frame shift mutations, addition or re-
moval of one or more codons, single or multiple exon deletion
or duplication, single or multiple intron deletion or duplica-
tion, single or multiple gene deletion or duplication and trans-
poson-induced mutations.
The pathophysiological consequences of these mutations
depend on the resulting changes in either the genetic regulatory
networks or the metabolic networks of the cell secondary todeﬁcient and/or defective synthesis of the gene product. The
resulting deterioration of gene function leading to pathogene-
sis of a genetic disorder correlates with the extent of deﬁciency
of the gene product, whether due to actual deﬁciency of the
protein or regulatory small RNA coded by the gene due to
suppression of gene function and inability to synthesize the
gene product, or to relative or absolute deﬁciency of the func-
tion of a faulty synthesized gene product. Deletion of large
portions of a gene, multiple exon deletions for instance, result
in the synthesis of grossly defective protein lacking most or
much of its domains needed to mediate its destined physiolog-
ical roles causing marked pathophysiological deteriorations in
the functioning metabolic networks dependent on these roles,
thus predisposing to development of genetic disorders.
Small mutations of bases involved in splisosome mecha-
nisms mediating intron excision and splicing of remaining
exons, as part of the post-transcription modiﬁcations of
mRNA, can have marked effects on the translation efﬁciency
of the ﬁnal mRNA and is a well-known mutational mechanism
that underlies the pathogenesis of many common and serious
genetic diseases (Fig. 2). These splice site mutations may result
in over excision of parts of adjacent exons and synthesis of
shorter polypeptide chains. If the missing amino acids coded
by the over excised parts are important for mediating protein
function or maintaining its structural integrity, then patho-
physiological alterations and pathogenesis of disease might
be expected. On the other hand, if splice site mutations result
in skipping of an intron, part of an intron, a whole intron or
multiple introns from excision, the resulting translated protein
might be large enough to be unstable and easily degradable, or
its structural conﬁguration might be altered in such a way that
Figure 2 Splice site mutations.
Basic concepts of medical genetics, pathogenetics, Part 2 119its functional domains are no more accessible to each other or
to other components, e.g. substrates or intermediary metabo-
lites, needed for mediating its physiological functions, and a
pathogenetic defect results [4].
1.3. Molecular mechanisms of gross mutations
Gross mutations are mutations that involve large portions of
the genetic material. Chromosomal aberrations represent the
prototype of this type of mutation, since even the smallest
functional portion of a chromosome may consist of tens to
hundreds of genes. Chromosomal abnormalities include many
types of mutations which may involve the number of chromo-
somes, numerical chromosomal abnormalities, or the structure
of chromosomes, structural chromosomal abnormalities.
These abnormalities might also be classiﬁed into autosomal
anomalies if they affect the autosomes (chromosomes 1–22)
and sex chromosomal anomalies if they involve the sex chro-
mosomes (X and Y chromosomes) [1].Chromosomal mutationsStructural mutations Numerical mutations1. Deletion 1. Trisomy (47 chromosomes)2. Translocation 2. Monosomy (45 chromosomes)3. Insertion 3. Hypodiploidy (less than 46)4. Ring chromosome
formation
4. Hyperdiploidy (more than 46)5. Dicentric chromosome
formation
5
c. Triploidy (3N: 69
hromosomes)6. Chromosome gaps
and breaks
6
c. Tetraploidy (4N: 92
hromosomes)Both categories of chromosomal abnormalities comprise
many different types of alterations in chromosome structure
(deletion, translocation, inversion, ring chromosome forma-
tion, etc) and in chromosome number (monosomy, trisomy,
hypodiploidy, hyperdiploidy, polyploidy, etc). Chromosome
gaps and breaks represent mutations leading to interruptionof the integrity of the chromosome DNA. They, probably, dis-
pose to development of many other types of structural aberra-
tions of chromosomes (Fig. 3).
The pathogenetic mechanisms involved in the pathogenesis
of chromosomal aberrations are, still, mysterious and hardly
understandable. They cannot be interpreted on molecular basis
even for chromosome gaps and breaks in view of the complex
structural assembly of the chromosome and its intimate integ-
rity with the chromatin material. Gross regulatory defects of
mechanisms controlling cell division, including the formation
of the spindle and the timing of its action in synchronization
with other biochemical and signal transduction effectors are
held responsible for predisposing to non-disjunction and the
development of chromosomal trisomies and chromosomal
monosomies as well. Similar defective regulatory mechanisms
might underlie the development of polyploidy conditions like
triploidy and tetraploidy [5].
However, the regular and persistent occurrence at nearly
constant incidence rates of well recognized and well deﬁned ge-
netic defects, including chromosomal aberrations, irrespective
of ethnic, racial or environmental factors, indicates that these
types of genetic changes or mutations might have, still un-
known, deep rooted signiﬁcant background in our genome.
Disclosure of master genes and related genetic factors respon-
sible for regulating both the stability and behavior of the gen-
ome as a whole will, surely, throw more light on factors
underlying pathogenesis and development of chromosomal
abnormalities.1.4. Molecular mechanisms of genomic mutations
Genomic mutations refer to mutations involving the whole
genome (either the 23 chromosomes haploid genome or the
46 chromosomes diploid genome). They comprise mutations
of the whole chromosome set of the genome like triploidy
(69 chromosomes genome) and tetraploidy (92 chromosomes
genome). They, also, include mutational events leading to
disturbed and/or defective expression of the whole genome
functions. Genomic functional mutations reveal their
Figure 3 Different types of chromosomal aberrations, breaks and rearrangements.
Figure 4 Some pathological consequences of genomic structural and functional mutations.
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development of vesicular or hydatidiform mole and theformation of dermoid cyst, instead of normal development
of the zygote, represent obvious examples of genomic
Basic concepts of medical genetics, pathogenetics, Part 2 121functional mutations. Normally, during the ﬁrst ﬁve days fol-
lowing fertilization and zygote formation, all cellular pro-
cesses including cell growth, differentiation and division are
controlled and mediated exclusively by the maternal genome
of the ovum. The sperm genome begins its participation in
these processes after these critical ﬁve days of post-fertiliza-
tion period. Improper temporal programing of these genomic
balances and interactions, e.g. due to genomic imprinting
mutations, leads to disturbed genomic regulation of develop-
ment and differentiation of the developing zygote, with dras-
tic consequences leading to actual cessation and disturbed
progress of normal development and differentiation. If the
maternal genome fails to start functioning properly after fer-
tilization or fails to maintain its genetic regulation of devel-
opment over the critical immediate post-fertilization period,
or if the paternal genome is prematurely induced to start
its roles in genetic regulation of development and differentia-
tion as a result of these genomic imprinting mutations, nor-
mal embryogenesis and/or fetal growth is brought to a
standstill [2].
Genomic functional mutations might, also, be caused by
other pathogenetic mechanisms, one of these abnormal mech-
anisms entails exclusive predominance of one parental genome
in zygote formation and development. The diploid genome of
the zygote may be formed from two maternal haploid genomes
(46, XX) without any sperm genome, or from two paternal
haploid sperm genomes (46,YY) without participation of any
maternal genome. These abnormalities in chromosomal consti-
tution of the zygote can be caused by many pathogenetic muta-
tional events. Endoreduplication of one parental genome of
the zygote with suppression, involution and disappearance of
the other genome, or fertilization of the ovum by two sperm
genomes with consequent disappearance of the ovum genome
from the developing zygote can lead to pathogenesis of these
genomic chromosomal abnormalities. A well-known wide
spectrum of pathological embryonic and fetal malformations
and abnormal conception products results from these genomic
functional mutations (Fig. 4) [6].Conﬂicts of interest
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1. MCQs – Medical genetics
1.1. Select only the best one answer for each question
1- Which of the following diagnostic techniques is of no value in the
diagnosis of neural tube defects:
A- Amniocentesis
B- Chorionic villus sampling (CVS)
C- Maternal serum screening
D- Ultrasonography
E- None of the above2- Which of the following conditions is NOT caused by a mutation
in FGFR3:
A- Achondroplasia
B- Crouzon syndrome
C- Thanatophoric dysplasia
D- Waardenburg syndrome
E- Hypochondroplasia3- Marfan syndrome is caused by mutations in the gene which
encodes:
A- Collagen
B- Ankyrin
C- Elastin
D- Spectrin
E- Fibrillin4- Ehlers–Danlos syndrome is caused by mutations in the gene
which encodes:
A- Collagen
B- Ankyrin
C- Elastin
D- Spectrin
E- Fibrillin5- Which of the following statements about Digeorge syndrome is
FALSE:
A- It is caused by large deletion on the long arm of chromosome 22
B- Patients suﬀer recurrent infections secondary to immune
deﬁciency
C- Occurrence is sporadic in about 85% of cases
D- An aﬀected person has a 50% chance of transmitting the
condition to his or her child.
E- Patients have hypocalcemia secondary to hypercalciuria6- Treatment of hyperammonemia due to urea cycle defects include
the following EXCEPT:
A- Peritoneal or hemodialysis
B- Lactulose
C- Sodium bicarbonate
D- Nitrogen scavenger drugs
E- Provision of high calories as carbohydrates and fats7- Precautionary measures during Valproic acid treatment of
seizures INCLUDE:
A- Close monitoring of liver functions
B- Close monitoring of serum ammonia level
C- Close monitoring of serum carnitine level
D- Periodic assay of serum drug level
E- All of the above
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syndrome can be attained via:
A- Molecular testing by mutation analysis
B- Biochemical study of collagen synthesis defects
C- Assay of urinary analyte
D- A, B and C
E- A and B9- The following statements about I-cell disease are true EXCEPT:
A- Psychomotor retardation is a major clinical manifestation
B- Bone marrow transplantation oﬀers radical cure of aﬀected
children
C- The commonest causes of death are pneumonia and/or
congestive heart failure
D- Linear growth decelerates during the ﬁrst year of life and ceases
by age of 2 years
E- There is traﬃcking defect of the synthesized enzyme to the
lysosome10- Chaperones are responsible for:
A- Participation in RNA splicing
B- Control of tRNA-amino acid binding
C- Regulation of protein traﬃcking inside the endoplasmic
reticulum
D- Regulation of protein assembly and correction of protein
misfolding
E- Apoptosis pathways11- Genetic hypertriglyceridemias can endanger life because of:
A- Biliary cirrhosis
B- Renal failure secondary to renal tubular dysfunction
C- Recurrent episodes of pancreatitis
D- Cerebral edema
E- Pulmonary ﬁbrosis12- Hypoglycemia is a common manifestation of the following
diseases EXCEPT:
A- Type O glycogen storage disease
B- Fatty acid oxidation defects
C- Galactosemia
D- Fructosemia
E- Maple syrup urine disease13- Each of the following is compatible with diagnosis of a
mitochondrial disorder EXCEPT:
A- Encephalopathy
B- Myopathy
C- Skin hypopigmentation
D- Lactic acidosis
E- Renal dysfunction14- Management of Turner syndrome patients include all of the
following EXCEPT:
A- Growth hormone supplementation
B- Ovarian hormones supplementation
C- Calcium supplementation
D- Omega 3 fatty acids supplementation
E- Regular checkup for gonadal malignancies15- Diagnostic features of Homocystinuria include none of the
following EXCEPT:
A- Persistent lactic acidosis
B- Truncal obesity
C- Brachydactyly
D- Delayed bone age
E- Visual defectsModel answers.
1 B 6 C 11 C
2 D 7 E 12 E
3 E 8 D 13 C
4 A 9 B 14 D
5 E 10 D 15 EReferences
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